Cargando…
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
BACKGROUND: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum inhibit...
Autores principales: | Feng, Zi-Han, Fan, Ling, Yang, Jing, Huo, Xing-Yue, Guo, Yan, Zhang, Yi, Lan, Chun-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683470/ https://www.ncbi.nlm.nih.gov/pubmed/31382897 http://dx.doi.org/10.1186/s12866-019-1558-8 |
Ejemplares similares
-
Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021) -
Antimicrobial susceptibility and clarithromycin resistance patterns of
Helicobacter pylori clinical isolates in Vietnam
por: Quek, Camelia, et al.
Publicado: (2016) -
Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020) -
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023) -
RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF
Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL
PATIENTS
por: Picoli, Simone Ulrich, et al.
Publicado: (2014)